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Men-who-have-sex-with-men (MSM) are at high risk of HIV and sexually transmitted infec-
tion (STI) transmission. Asymptomatic STIs are common in MSM and remain undiagnosed
and untreated where syndromic management is advocated. Untreated STIs could be con-
tributing to high HIV rates. This study investigated symptomatic (SSTI) and asymptomatic
STIs (ASTIs) in MSM in Cape Town.
Methods
MSM, 18 years and above, were enrolled into this study. Participants underwent clinical and
microbiological screening for STIs. Urine, oro-pharyngeal and anal swab specimens were
collected for STI analysis, and blood for HIV and syphilis screening. A psychosocial and
sexual questionnaire was completed. STI specimens were analysed for Neisseria gonor-
rhoeae (NG) and Chlamydia trachomatis (CT) infection.
Results
200 MSM were recruited with a median age of 32 years (IQR 26–39.5). Their median num-
ber of sex partners within the last year was 5 (IQR 2–20). 155/200 (78%) reported only male
sex partners while 45/200 (23%) reported sex with men and women. 77/200 (39%) reported
transactional sex. At enrolment, 88/200 (44%) were HIV positive and 8/112 (7%) initially
HIV-negative participants seroconverted during the study. Overall, 47/200 (24%) screened
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positive for either NG or CT. There were 32 MSM (16%) infected with NG and 7 (3.5%) of
these men had NG infections at two anatomical sites (39 NG positive results in total). Like-
wise, there were 23 MSM (12%) infected with CT and all these men had infections at only
one site. Eight of the 47 men (17%) were infected with both NG and CT. ASTI was more
common than SSTI irrespective of anatomical site, 38 /200 (19%) versus 9/200 (5%)
respectively (p<0.001). The anus was most commonly affected, followed by the oro-pharynx
and then urethra. Asymptomatic infection was associated with transgender identity (OR
4.09 CI 1.60–5.62),5 male sex partners in the last year (OR 2.50 CI 1.16–5.62) and trans-
actional sex (OR 2.33 CI 1.13–4.79) but not with HIV infection.
Conclusions
Asymptomatic STI was common and would not have been detected using a syndromic
management approach. Although molecular screening for NG/CT is costly, in our study only
four MSM needed to be screened to detect one case. This supports dual NG/CT molecular
screening for MSM, which, in the case of confirmed NG infections, may trigger further cul-
ture-based investigations to determine gonococcal antimicrobial susceptibility in the current
era of multi-drug resistant gonorrhoea.
Introduction
Men-who-have-sex-with-men (MSM) are at high risk of acquiring and transmitting HIV and
other sexually transmitted infections (STIs) and MSM have been identified as a key population
requiring targeted HIV prevention interventions. [1–5] The prevalence of HIV among South
African MSM is high with an estimated range of 10–43%. [6–9] Reasons for this are complex
and include high biological risk of HIV transmission during unprotected receptive penile-anal
sex (compared to penile-vaginal sex) in addition to behavioural and sexual network factors.
[10,11] Furthermore, the presence of prior STIs is associated with increased HIV vulnerability
among MSM and treating STIs is believed to be a valid strategy for decreasing HIV transmis-
sion. [2]
Anatomical sites of sexual infection in MSMmay differ from those in men who have sex
exclusively with women, and include oro-pharyngeal and anal infections. STIs at these sites
may be symptomatic (SSTI) or asymptomatic (ASTI) and asymptomatic disease is more likely
to be inadequately diagnosed and treated. [12,13] South Africa obligates the use of syndromic
management of STIs for all patients utilizing the public sector health system. Syndromic man-
agement is a tool for managing symptomatic STIs and inherently does not allow for diagnosis
of ASTI and therefore may not be responsive to the health needs of MSM. [14,15] In addition,
South African STI guidelines do not include guidance on how to manage ano-rectal discharge
as a syndrome.
Due to the high incidence of ASTIs among MSM globally, the World Health Organization
has produced guidelines advocating for empiric STI treatment in asymptomatic high-risk
MSM. [2,15] Few data are available for South Africa and indeed for most African countries to
allow for the assessment of the suitability of this recommendation. A study in 43 MSM in
Kenya reported that 11 (26%) screened positive for either Neisseria gonorrhoeae (NG) or Chla-
mydia trachomatis (CT) infection. Only 2 out of 43 participants reported symptoms, i.e. the
majority of infections were asymptomatic and these patients would not have been treated
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unless screening had taken place. However, they would have benefited from empiric ASTI
treatment according to the WHO guidance. [13]
Rationale and Aims
Screening for both SSTIs and ASTIs in MSM has become standard of care in many developed
world nations but does not occur in the state healthcare sector in South Africa and many devel-
oping nations. [2,15,16] The burden of STIs and ASTIs in South African MSM remains
unknown and, due to the lack of clinical services with high numbers of MSM attendees, no sys-
tematic surveillance is occurring. [14] Similarly, the contribution of sexual infections to high
HIV rates among local MSM remains poorly understood and described.
This study aimed to describe the burden of symptomatic and asymptomatic NG/CT infec-
tion in MSM attending the Ivan Toms Centre for Men’s Health (ITCMH). Secondary aims
included investigation of risk factors associated with molecular detection of NG/CT, including




State-sector MSM-targeted sexual health services have existed in South Africa since 2009 when
the Anova Health Institute’s Health4Men programme was launched as a collaborative project
with the Department of Health with support and funding from PEPFAR/USAID. [17] The lon-
gest running of these services is the Ivan Toms Centre for Men’s Health (ITCMH) in Cape
Town which functions as a centre of excellence for developing and delivering locally-appropri-
ate MSM sexual health care. This clinic has provided services to more than 6,500 MSM to date.
[18,19] The clinic is a primary-level, sexual health and wellness service focusing on HIV and
STI diagnosis, treatment and prevention and includes biomedical, psychosocial, educational
and community components. The ITCMH is situated alongside major car, taxi and train com-
muter routes and attracts MSM clients with a range of sexual identities from a wide geographic
catchment area surrounding Cape Town. Since the clinic attracts clients from such a diverse
spectrum of MSM in different geographic areas, and with diverse socio-economic status and
cultural backgrounds, it is likely that MSM attending the clinic are broadly representative of
urban and peri-urban MSM in and around the City of Cape Town.
Recruitment
All MSM clients attending the clinic between January-July 2012 were screened for enrolment
irrespective of their reason for attendance. Only two potential study participants declined
enrolment after screening. A sample of 200 consecutive MSM attending the ITCMH in Cape
Town was enrolled. The importance of screening for and treating both symptomatic and
asymptomatic STIs was promoted at community level by Health4Men outreach officers, events
in public spaces frequented by MSM and by staff at the ITCMH.
Inclusion criteria were: over 18 years of age, sex (insertive or receptive, oral or anal sex or
anilingus) with another man within the previous year and ability to understand the study and
provide informed consent to participate. MSM were excluded if they were taking treatment for
a recent STI or had taken such treatment in the past two weeks prior to study screening, or
were unavailable to attend the clinic for a follow-up study visit. Ethical approval for this study
was obtained from the University of Cape Town Human Sciences Research Ethics Committee.
(Protocol number: HSREC 419/2011.) All study participants provided written informed
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consent prior to study enrolment. The study complies with the Helsinki Declaration and all
principles of Good Clinical Practice.
Study Activities
Enrolled participants attended two study-related visits two weeks apart. At the first visit, partic-
ipants completed researcher-administered interviews. Symptoms of urethral, anal and oro-
pharyngeal pain, discharge, itch or irritation were assessed. A clinical examination to identify
STIs and HIV-related clinical conditions was performed by a qualified clinician with experi-
ence in providing health care to MSM. Participants provided self-collected urine and clinicians
collected rectal and oro-pharyngeal swabs. Phlebotomy was performed for syphilis and HIV
testing where status was unknown or uncertain. HIV positive participants had a CD4 count
performed. All newly diagnosed HIV positive participants received appropriate HIV counsel-
ling and linkage to care.
At the second study visit, participants were informed of their specimen results and diag-
nosed infections were treated with appropriate antibiotics as per in-country guidelines. [15]
Gonorrhoea was treated with single-dose cefixime 400mg orally and chlamydial infections
were treated with doxycycline 100mg orally 12 hourly for seven days. Sexual contacts were
traced for treatment and where necessary, patients were linked back to the ITCMH for relevant
chronic care. At both study visits, participants received sexual risk-reduction counselling, con-
doms and latex-compatible sexual lubricants and a range of information and educational
materials.
Laboratory Analysis
Urine, oro-pharyngeal and anal swabs were analysed for NG/CT infection using the RNA-
based Aptima Combo 2 assay (Hologic-Gen-Probe, San Diego, CA, USA). Syphilis analysis
was performed using rapid kit SD Bioline syphilis 3.0 test (Standard Diagnostics, Gyeonggi-do,
Republic of Korea). Positive results were confirmed using the Immunotrep Carbon Antigen
rapid plasma reagin (RPR) and the Immunotrep Treponema pallidum haemagglutination assay
(Omega Diagnostics, Alva, United Kingdom). HIV testing utilized serial rapid kit ELISA meth-
odology. The SD Bioline HIV 1/2 3.0 test kit (Standard Diagnostics, Gyeonggi-do, Republic of
Korea) was used for initial screening and positive results were confirmed with the Determine
HIV-1/2 kit (Alere Medical, Matsuhidai, Japan). Positive results on both rapid kits were con-
sidered to be truly HIV positive. A single negative kit result was regarded as a true negative but
study participants were counselled to undergo post-window period re-testing. Pan-leucogated
CD4 analysis was performed for all HIV positive participants (Beckman Coulter, Brea, CA,
USA).
Data Analysis
Data were analysed using Stata 12.0 (Stata Corporation, College Station, TX, USA). Descriptive
statistics (proportions, means with SD, medians with IQR) were used to summarize the data.
Bivariate analysis employed chi-squared and Fishers exact tests (for comparisons of propor-
tions) and Kruskall-Wallis tests (for comparisons of medians).
Results
200 MSM were enrolled during the recruitment period. Their median age was 32 years (IQR
26–39.5 years). All participants lived locally in Cape Town or its surrounds, with a significantly
greater proportion of black participants, 40/200 (65%), living in peri-urban areas compared to
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the other racial groups. Most (73%) of participants had completed high school, 42% had a ter-
tiary level qualification and 68% were employed in full or part-time work. A total of 83/200
(42%) of participants were circumcised. Of these, 56 (28%) were medical circumcisions and 27
(14%) were traditional circumcisions. Baseline characteristics of the participants by population
group and the range of sexual activities and risk behaviours are summarized in Table 1.
More than half the participants (52%) reported having a boyfriend whom we defined as the
primary sexual partner. The median number of sex partners in the year prior to recruitment
was 5 (IQR 2–20). One hundred and fifty-five participants (78%) reported sex with men only
and 45/200 (23%) reported sex with men and women. Any transactional sex was reported by
77/200 (38%); 12% reporting having paid for sex, 18% received payment for sex and 8% paid
for and received payment for sex.
Fifty seven (29%) reported clinical symptoms suggestive of an STI: 10(5%) had a urethral
discharge, 26(13%) reported oro-pharyngeal pain and 22 (11%) reported anal discharge or
pain. Overall, 47 participants (23%) had a previous diagnosis of an STI in the 12 months prior
to enrolment and 21 (10%) had been previously been treated for syphilis.
STI results are summarised in Fig 1 and Table 2.
Overall, 47/200 (24%) screened positive for either NG or CT. There were 32 MSM (16%)
infected with NG and 7 of these men had NG infections at two anatomical sites (39 NG positive
results in total). Likewise, there were 23 MSM (12%) infected with CT and all these men had
infections at only one site. Eight of the 47 men (17%) were infected with both NG and CT.
Nine of 200 (5%) of study participants with these infections were symptomatic whilst 38/
200 (19%) were asymptomatic despite testing positive for either NG or CT or both. Gonor-
rhoea was more likely to be asymptomatic in the pharynx or anus compared to the urethra
(P<0.05) but no such difference was seen for chlamydial infections since all urethral chlamydia
infections in this study were asymptomatic. Of those who screened negative for NG or CT, 48/
153 (31%) reported symptoms that would have incorrectly resulted in empiric STI manage-
ment if empiric syndromic guidelines were used.
Eighty-eight (44%) participants had prevalent HIV at enrolment and 8/112 (7%) of initially
HIV negative participants were newly diagnosed with HIV during the study. The mean CD4
count of HIV positive MSM was 420 cells/mm3 (SD 176.8 cells/ mm3) and 46/88 (52%) were
receiving antiretroviral therapy (ART). No statistically significant difference in SSTI or ASTI
by HIV status was found, except for syphilis, which was more common among HIV positive
participants. Refer Table 3.
In further bivariate analysis, ASTI was strongly associated with identifying as transgender as
opposed to MSM or gay (OR = 4.09, CI 1.38–12.12), having five or more male sex partners
within the past 12 months compared to fewer than 5 partners (OR = 2.56, CI 1.16–5.62) and
engaging in transactional sex in the past year compared to reporting no transactional sex
(OR = 2.33, CI 1.13–4.79). Having insertive oral sex, compared to those reporting no insertive
oral sex, appeared to be protective (OR = 0.38, CI 0.17–0.87) but when compared to receptive
oral sex, there was no significant protective effect (OR = 0.52, CI 0.16–1.64) but this was likely
due to the small sample size. Refer Table 4.
In a separate analysis, risk factors for any STI (SSTI and ASTI) included having had an STI
diagnosis in the past year (OR = 3.00, CI 1.52–5.94), having had sex under the influence of
drugs in the last six months (OR = 2.12, CI 1.11–4.07), having had sex with an internet-sought
partner in the past year (OR = 1.98, CI 1.07–3.66) and having had sex at a sex-on-site venue in
the past year (OR = 1.92, CI 1.02–3.64). Logistic regression modelling suggested that these
associations were not significantly confounded by age (data not shown).
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Table 1. Baseline Characteristics, Sexual Behaviour and STI Risks Stratified by Population Group.
Variable All Patients (N = 200) Black 62 (31%) White 71 (36%) Coloured /Other 67 (33%) P value
Baseline characteristics stratified by population group
Age [years (IQR)] 32 (26–39.5) 29 (24–35) 34 (27–44) 32 (26–39) 0.001
Gender
Male 185 (93%) 55 (89%) 71 (100%) 59 (88%)
Transgender women 15 (8%) 7 (11%) 0 8 (12%) 0.011
Education
Completed high school 145 (73%) 45 (73%) 63 (89%) 37 (55%) <0.001
Tertiary qualification 84 (42%) 22 (35%) 46 (65%) 16 (24%) <0.001
Residence
City or suburbs 147 (73.5%) 22 (35%) 64 (90%) 61 (91%)
Peri-urban 53 (26.5%) 40 (65%) 7 (10%) 6 (9%) <0.001
Employed 137 (68%) 39 (63%) 54 (76%) 44 (66%) 0.220
Cell phone 159 (79.5%) 52 (84%) 68 (96%) 39 (58%) <0.001
Internet Access 151 (75.5%) 44 (71%) 68 (96%) 39 (58%) <0.001
Total circumcised 83 (42%) 33 (53%) 28 (39%) 22 (33%) 0.058
Sexual behavior characteristics in the past 12 months (last 10 sex partners) and other risk factors for STIs stratified by population group
Sex with
Men only 155 (78%) 48 (77%) 65 (92%) 42 (63%)
Men and women 43 (22%) 14 (23%) 6 (8%) 25 (37%) <0.001
Number of male sex partners (median and IQR) 5 (2–20) 5 (2–12) 5 (3–20) 6 (2–24) 0.803
<5 male sex partners 88 (44%) 27 (44%) 33 (46%) 28 (42%)
5 male sex partners 112 (56%) 35 (56%) 38 (54%) 39 (58%) 0.854
Group sex in the past year 59 (30%) 16 (26%) 27 (38%) 16 (24%) 0.142
Sex under influence of alcohol (ever) 137 (69%) 45 (73%) 49 (69%) 43 (64%) 0.587
Sex under influence of drugs (ever) 105 (53%) 14 (23%) 45 (63%) 46 (69%) <0.001
Crystal methamphetamine use (ever) 73 (37%) 12 (19%) 23 (32%) 38 (57%) <0.001
Any transactional sex in past year 77 (38.5%) 22 (35%) 16 (23%) 39 (58%) <0.001
None 123 (62%) 40 (64%) 55 (77%) 28 (42%)
Paid for sex 24 (12%) 6 (10%) 11 (16%) 7 (10%)
Received payment for sex 36 (18%) 13 (21%) 3 (4%) 20 (30%)
Paid for and received payment for sex 17 (8%) 3 (5%) 2 (3%) 12 (18%) <0.001
STI-diagnosis in the past year 47 (23%) 20 (32%) 13 (18%) 14 (21%) 0.138
HIV test in past year
No (or don’t know result) 93 (46.5%) 34 (55%) 30 (42%) 29 (43%)
Yes 107 (53.50%) 28 (45%) 41 (58%) 38 (57%) 0.283
Type of Sex in the last 12 months *
Insertive anal sex 143 (72%) 37 (60%) 61 (86%) 45 (67%) 0.002
Receptive anal sex 140 (70%) 47 (76%) 55 (77%) 38 (57%) 0.014
Both (insertive and receptive) anal sex 92 (46%) 24 (39%) 49 (69%) 19 (28%) <0.001
Insertive oral sex 163 (82%) 39 (63%) 67 (94%) 57 (85%) <0.001
Receptive oral sex 174 (87%) 46 (74%) 69 (97%) 59 (88%) <0.001
Both (Insertive and receptive) oral sex 149 (75%) 33 (53%) 66 (93%) 50 (75%) 0.023
Performed analingus (rimming) 77 (39%) 18 (29%) 38 (54%) 21 (31%) 0.005
Received rimming 96 (48%) 25 (40%) 38 (54%) 33 (49%) 0.305
Both performed and received rimming 62 (31%) 16 (26%) 27 (38%) 19 (28%) 0.116
* Participants may have reported engaging in more than one of the sexual activity categories listed in this table.
doi:10.1371/journal.pone.0138315.t001
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Discussion
This study is the first to investigate asymptomatic NG/CT infections among MSM in South
Africa. A high burden of NG/CT infection (24% screened positive for NG/CT at any site) was
demonstrated in our participants, most of whom were asymptomatic. This is similar to rates
found in other African developing nations. A study from coastal Kenya reported that 11/43
(26%) (95% CI 14–41%) screened positive for NG or CT or both. [13] A later study from the
Fig 1. Symptomatic and asymptomatic gonorrhoea and chlamydia by site of infection.
doi:10.1371/journal.pone.0138315.g001
Table 2. Symptomatic and asymptomatic Gonorrhoea and Chlamydia by site of infection.
N. gonorrhoeae site-related
infections in 32 MSM1
C. trachomatis site-related
infections in 23 MSM
Dual infections at the same site
(n = 72)
Symptomatic Asymptomatic Symptomatic Asymptomatic Symptomatic Asymptomatic
Anal 3 (8%) 14 (36%) 2 (9%) 14 (61%) 2 (29%) 5 (71%)
Oro-pharyngeal 3 (8%) 12 (31%) 0 0 0 0
Urethral 7 (18%) 0 0 7 (30%) 0 0
Any 13 (33%) 26 (67%) 2 (9%) 21 (91%) 2 (29%) 5 (71%)
Total MSM with symptomatic NG/CT infections: 9/200 (5%)
Total MSM with asymptomatic NG/CT infections: 38/200 (19%)
Total proportion of ASTIs were significantly more common than total proportion of SSTIs, p <0.001
1 Seven MSM had dual N. gonorrhoeae and C. trachomatis infections at the same anatomical site
2 There was one MSM with dual infection at different anatomical sites (NG positive in oro-pharynx and CT positive in urine)
doi:10.1371/journal.pone.0138315.t002
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same researchers documented a 3 month incidence of any rectal NG/CT asymptomatic infec-
tion in men reporting unprotected receptive anal sex of 39% (95% CI 24–65%).[20] A study
investigating rectal STIs among a sample of 172 MSM in two cities in Tanzania reported rates
of curable STIS (NG/CT and syphilis) as 21% (large metropolis) and 4.4% (provincial city).
[21] Similar rates of asymptomatic infection have been reported in the USA: 24% NG or CT
infections among a cohort of 99 HIV positive US Marine Corps men, and 38% with rectal NG
or CT infections in 326 MSM attending an STI clinic in the US Midwest. [22,23]
Results from our study demonstrate risky sexual behaviours among local MSM. Enrolled
participants had a median of five partners within the past year, condom use was low, transac-
tional sex was common and almost half the participants were HIV positive. Almost a quarter
had been diagnosed and treated for an STI in the past 12 months. These data demonstrate the
need for effective HIV and STI prevention interventions that are MSM-focused.
High rates of asymptomatic NG/CT are of particular relevance to resource-limited settings
where STIs are managed syndromically and most asymptomatic STIs remain untreated due to
lack of laboratory-based screening policies, even in key populations at high risk of STI acquisi-
tion, such as MSM. The inability to diagnose asymptomatic STIs in MSM leads to under-treat-
ment, poor STI control and possibly drives HIV transmission in this high HIV-risk
population. The relationship between STIs and HIV is a complex one which has been
Table 3. Sexually transmitted infections by HIV sero-status.
Variable n (%) Total (n = 200) HIV-positive 88 (44%) HIV-negative 112 (56%) P.value
Active Syphilis (TPHA/rapid and RPR Positive) 22 (11%) 18 (20%) 4 (4%) <0.001
Syphilis (RPR Positive) 23 (12%) 19 (22%) 4 (4%) <0.001
Syphilis (TPHA Positive) 21 (11%) 17 (19%) 4 (4%) <0.001
Chlamydial Infection
Urethral 7 (3.5%) 0 (0%) 7 (6%) 0.017
Anal 16 (8%) 8 (9%) 8 (7%) 0.614
Any site 23 (11.5%) 8 (9%) 15 (13%) 0.344
Gonorrhoea
Urethral 7 (3.5%) 2 (2%) 5 (4%) 0.403
Oro-pharyngeal 15 (8%) 7 (8%) 8 (7%) 0.829
Anal 17 (8%) 11 (13%) 6 (5%) 0.072
Any site 32 (16%) 17 (19%) 15 (13%) 0.257
Chlamydial & Gonorrhoea Co-infection 8 (4%) 5 (6%) 3 (3%) 0.282
Any NGCT 47 (23.5%) 20 (23%) 27 (24%) 0.819
Symptomatic and NG/CT positive 9/47 (19%) 4 (20%) 5 (19%) 0.898
Asymptomatic and NG/CT positive 38/47 (81%) 16 (80%) 22 (81%)
All STI 60 (30%) 31 (35%) 29 (26%) 0.153
Clinical Diagnosis
Urethritis 11 (5.5%) 3 (3%) 8 (7%) 0.250
Pharyngitis 8 (4%) 2 (2%) 6 (5%) 0.269
Proctitis 5 (2.5%) 3 (3%) 2 (2%) 0.465
Other 85 (42.5%) 46 (52%) 39 (35%)
STI diagnosis in the past 12 months
Overall 47 (23.5%) 28 (32%) 19 (17%) 0.014
Urethral discharge 16/47 (34%) 7/28 (25%) 9/19 (47%) 0.112
Genital herpes 3/47 (6%) 1/28 (4%) 2/19 (11%) 0.338
Syphilis 21/47 (45%) 16/28 (57%) 5/19 (26%) 0.037
Anal HPV 4/47 (9%) 2/28 (7%) 2/19 (11%) 0.544
doi:10.1371/journal.pone.0138315.t003
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examined in many studies. It is biologically plausible that STIs are a driver of HIV transmission
as they cause gaps in mucosal integrity as well as promoting inflammation which drives HIV
replication. [24,25,26] Studies have demonstrated a link between urethral STIs and increases in
HIV viral load, although there have also been negative studies in this regard. [24,27] A US-
based study modelled the effect of STIs on HIV rates among young MSM in Chicago and
reported that approximately 15% of new HIV infections in this model were attributable to NG/
CT infections. [28] The proportion of HIV infections attributable to NG/CT has not been mod-
elled for South African MSM, however data are available to show this relationship in cohorts of
South African women. [29] No formal meta-analysis has been conducted to answer these ques-
tions among MSM, although the World Health Organisation has assessed relevant data and
has recommended that screening and treatment of STIs should form part of the core package
or HIV risk reduction among MSM.
Additionally, the correlation between symptoms and microbiologically confirmed STIs was
poor in our study which emphasizes the well-recognized over-treatment associated with the
Table 4. Factors associated with asymptomatic STIs (Gonorrhoea and Chlamydia).
Variable ASTI Crude OR (95% CI)
Age (years) 0.97 (0.93–1.01)
Gender
Male 1.00
Transgender women 4.09 (1.38–12.12)
Completed high school (versus not) 1.06 (0.47–2.37)
Residence
City or suburbs 1.00
Peri-urban 0.85 (0.37–1.94)
Employed (versus not) 0.48 (0.23–1.00)
Male Circumcision (MC)




Men and women 0.61 (0.24–1.57)
Number of male sex partners
<5 male sex partners 1.00
5 male sex partners 2.56 (1.16–5.62)
Sex under influence of alcohol. Ever (versus never) 0.85 (0.40–1.81)
Sex under influence of drugs. Ever (versus never) 1.59 (0.77–3.29)
Crystal Methamphetamine use 1.8 (0.88–3.70)
Transactional Sex in past year (versus not) 2.33 (1.13–4.79)
STI-diagnosis in the past year (versus not) 1.97(0.89–4.37)
HIV positive (versus negative) 0.91 (0.44–1.87)
Type of Sex in the last 12 months
Insertive anal sex 0.79 (0.37–1.72)
Receptive anal sex 1.28 (0.58–2.85)
Insertive oral sex 0.38 (0.17–0.87)
Receptive oral sex 0.88 (0.30–2.54)
Performed rimming 0.88 (0.42–1.83)
Received rimming 0.94 (0.46–1.91)
doi:10.1371/journal.pone.0138315.t004
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syndromic management approach. Although most NG/CT cases were diagnosed in asymptom-
atic MSM, the majority of asymptomatic MSM were not infected with either pathogen. There-
fore, following the WHO recommendations for empiric treatment of STIs among high risk
asymptomatic MSM would also result in substantial over-treatment. The degree of overtreat-
ment could be reduced if NG/CT treatment could be targeted at those MSM defined risk fac-
tors for NG/CT infections. Our study suggests that MSM could be prioritized for targeted STI
screening if they have had (i) an STI diagnosis in the past year, (ii) sex under the influence of
drugs in the last six months, (iii) sex with an internet-sought partner in the past year, or (iv)
sex at a sex-on-site venue.
The high cost of molecular detection of STIs remains a significant barrier to appropriate STI
services in South Africa and other resource-poor nations (approximately $150 per participant
to screen three anatomical sites). Cheaper platforms, and ideally rapid point-of-care tests,
would be necessary before NG/CT screening could be incorporated into standard practice.
Nevertheless, our data demonstrate that only four MSM clients would need to be screened in
order to diagnose an STI, making a strong case for directed screening in MSM.
The World Health Organization currently recommends intermittent empiric treatment for
asymptomatic STIs among high risk MSM [2]. Given that gonococcal cephalosporin resistance
rates are increasing globally, that resistance is more common in MSM compared to heterosex-
ual people and that cases of resistance and treatment failure are now being detected in South
African MSM, targeted screening, with subsequent bacteriological culture and antimicrobial
susceptibility testing for those MSM diagnosed with gonorrhoea, may be a preferable strategy.
[12,14,30] Based on the high incidence of ASTIs demonstrated in this MSM study cohort, we
recommend at least sentinel screening of MSM in centres of excellence for MSM health care to
determine asymptomatic rates. For countries that are unable to operationalize sentinel or wide-
spread direct screening for financial, logistic or other reasons, following the WHO guideline
for empiric STI treatment for high risk MSM remains the best current approach.
Potential weaknesses of our study include the relatively small sample size which limited the
statistical power for investigation of associations during study data analysis. Also study partici-
pants were recruited from a well-known MSM clinic in metropolitan Cape Town (i.e. a clinic-
based sample) and may not be representative of other MSM in South Africa or globally. STIs
other than NG/CT are not the focus of this paper and will be reported in future publications.
Despite these weaknesses, data from this study provide important insights into the STI disease
burden among South African MSM and may assist health planners and implementers to
improve targeted programs in an evidence-based manner: something that has been difficult
given the general lack of knowledge relating to STIs in African MSM.
Conclusions
In conclusion, it is important to find the correct balance between cost effective empiric treatment
of symptomatic STIs and expensive screening for asymptomatic STIs in key populations at high
risk of HIV infection. More research is required in this field to inform health planners how best
to design and implement such programs. Also, since STI and HIV rates are likely to vary between
populations and geographic settings, local health planners will need to ensure that existing guid-
ance is relevant to their epidemiological setting. Our data support the recommendation of senti-
nel screening of STIs amongMSM for countries that can afford such programs.
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